Contact Us
Artificial Intelligence In Oncology Global Market Report 2025
Global Artificial Intelligence In Oncology Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Artificial Intelligence In Oncology Global Market Report 2025

By Component (Software Solutions, Hardware, Services), By Treatment Type (Chemotherapy, Radiotherapy, Immunotherapy, Other Treatment Types), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Cancer Types), By Application (Cancer Detection, Drug Discovery, Drug Development, Other Applications), By End-Users (Hospitals, Diagnostic Centers, Pharmaceutical Companies, Research Institutes, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Artificial Intelligence In Oncology Market Overview

• Artificial Intelligence In Oncology market size has reached to $1.78 billion in 2024

• Expected to grow to $7.55 billion in 2029 at a compound annual growth rate (CAGR) of 34%

• Growth Driver: AI In Oncology Market Surges As Cancer Incidence Continues To Rise

• Market Trend: Innovative Cloud-Based Software Revolutionizes AI In Oncology Market

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Artificial Intelligence In Oncology Market?

Artificial intelligence in oncology refers to applying artificial intelligence (AI) technologies and techniques in cancer diagnosis, treatment, research, and patient care. The goal of AI in oncology is to improve outcomes for cancer patients by leveraging computational methods to identify patterns, predict outcomes, and support evidence-based decision-making across the continuum of cancer care.

The main components of artificial intelligence in oncology are software solutions, hardware, and services. Software solutions in the field of oncology leverage artificial intelligence (AI) to enhance various aspects of cancer diagnosis, treatment, and research. The various treatment types include chemotherapy, radiotherapy, immunotherapy, and others. The various cancer types include breast cancer, lung cancer, prostate cancer, colorectal cancer, brain tumor, and others. These are used in various applications such as cancer detection, drug discovery, and drug development, and also by various end-users such as hospitals, diagnostic centers, pharmaceutical companies, research institutes, and others.

Artificial Intelligence In Oncology Market Size and growth rate 2025 to 2029: Graph

What Is The Artificial Intelligence In Oncology Market Size 2025 And Growth Rate?

The artificial intelligence in oncology market size has grown exponentially in recent years. It will grow from $1.78 billion in 2024 to $2.35 billion in 2025 at a compound annual growth rate (CAGR) of 31.5%. The growth in the historic period can be attributed to rising cancer incidence, data proliferation in healthcare, clinical trial optimization, demand for personalized medicine, efficiency in radiology and pathology.

What Is The Artificial Intelligence In Oncology Market Growth Forecast?

The artificial intelligence in oncology market size is expected to see exponential growth in the next few years. It will grow to $7.55 billion in 2029 at a compound annual growth rate (CAGR) of 34.0%. The growth in the forecast period can be attributed to integration with electronic health records (EHR), expanded applications in treatment decision support, patient engagement and education, regulatory support, and standardization. Major trends in the forecast period include integration of natural language processing (NLP) in healthcare, utilization of AI in biomarker discovery, focus on explainable AI for clinical adoption, integration of AI in population health management, collaborations between AI developers and healthcare providers, advancements in predictive analytics.

The forecast of 34.0% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. cancer care by increasing costs for Artificial intelligence(AI)-powered tumor board platforms and precision oncology matching systems imported from Germany and South Korea, potentially delaying treatment plans and raising oncology center expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Artificial Intelligence In Oncology Market Segmented?

1) By Component: Software Solutions, Hardware, Services

2) By Treatment Type: Chemotherapy, Radiotherapy, Immunotherapy, Other Treatment Types

3) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Cancer Types

4) By Application: Cancer Detection, Drug Discovery, Drug Development, Other Applications

5) By End-Users: Hospitals, Diagnostic Centers, Pharmaceutical Companies, Research Institutes, Other End Users

Subsegments:

1) By Software Solutions: Diagnostic Software, Treatment Planning Software, Patient Management Software, Data Analytics Platforms

2) By Hardware: AI-Enabled Imaging Devices, High-Performance Computing Systems, Wearable Health Monitors

3) By Services: Consulting Services, Integration Services, Maintenance And Support Services

What Is Driving The Artificial Intelligence In Oncology Market? AI In Oncology Market Surges As Cancer Incidence Continues To Rise

The rising incidence of cancer cases is expected to propel the growth of the AI in oncology market going forward. Cancer is a complex group of diseases characterized by the uncontrolled growth and division of abnormal cells in the body. The integration of AI into oncology has the potential to revolutionize cancer care by making IT more precise, personalized, and efficient. For instance, in 2023, according to a report by the American Cancer Society Inc., a US-based voluntary health organization, the estimated number of new cancer cases increased from 1.8 million to 1.9 million. Therefore, the rising incidence of cancer cases is driving the growth of the AI in oncology market.

What Is Driving The Artificial Intelligence In Oncology Market? Rising Adoption Of Cloud-Based Applications And Services By Pharmaceutical Companies

The rising adoption of cloud-based applications and services by pharmaceutical companies will contribute to the growth of AI in the oncology market going forward. The adoption of cloud-based applications and services in oncology has been steadily increasing due to their numerous benefits. Cloud computing enables researchers to access and analyze large-scale data, including genomics, proteomics, metabolomics, transcriptomics, and clinical and epidemiological data. This has proven particularly useful in accelerating cancer research for precision medicine. For instance, in June 2024, according to AAG IT Services, a UK-based non-government organization, in 2022, 89% of organizations surveyed used multi-cloud solutions for their storage and workloads. Only 9% utilized a single public cloud, with 2% relying on a single private cloud. Therefore, pharmaceutical companies' increasing adoption of cloud-based applications and services will drive artificial intelligence in oncology industry.

Who Are The Major Players In The Global Artificial Intelligence In Oncology Market?

Major companies operating in the artificial intelligence in oncology market report are Azra AI, IBM Corporation, Siemens Healthcare GmbH, Intel Corporation, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI Inc., PathAI Inc., Median Technologies SA, Kheiron Medical Technologies Ltd., Hampton Research Inc., Tempus Labs Inc., Paige AI Inc., Prognos Health Inc., Enlitic, Inspirata Inc., Berg LLC, Proscia Inc., Prognos Health Inc., Deep 6 AI Inc., Ibex Medical Analytics, Nanox Imaging Ltd., Zebra Medical Vision, Globavir Biosciences Inc.

What Are The Key Trends Of The Global Artificial Intelligence In Oncology Market? Innovative Cloud-Based Software Revolutionizes AI In Oncology Market

Major companies operating in the AI in the oncology market are focusing on developing innovative software, such as cloud-based software, to enhance their efficacy and provide improved solutions. Cloud-based software plays a crucial role in AI applications in oncology by providing a scalable, flexible, and accessible platform for processing and analyzing large volumes of medical data. For instance, in March 2023, Illumina Inc., a US-based biotechnology company, launched Connected Insights, a new cloud-based software enabling tertiary analysis for oncology applications. With the help of the integration of external knowledge bases, Connected Insights streamlines the interpretation and reporting of results from various assay types, allowing labs to expand their usage of NGS (Next-Generation Sequencing) and speed up the turnaround time for clinical reporting.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Artificial Intelligence In Oncology Market? Lunit Acquires Volpara Health Technologies to Enhance Cancer Diagnostics in the U.S. Market

In May 2024, Lunit, a South Korea-based medical solutions company, acquired Volpara Health Technologies for $ 193 million amount. This acquisition of Lunit's aim is to create a formidable alliance in the cancer diagnostics industry, particularly in the U.S. market. By combining their strengths, Lunit seeks to enhance its AI-driven solutions for early cancer detection and improve patient care. Volpara Health Technologies is a New Zealand-based healthcare software company, that develops and sells breast cancer detection and diagnosis tools.

Regional Outlook For The Global Artificial Intelligence In Oncology Market

North America was the largest region in the AI in oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Artificial Intelligence In Oncology Market?

The artificial intelligence in oncology market consists of revenues earned by entities by providing services such as surgery, targeted therapy, and stem cell transplantation. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence in the oncology market also includes sales of edge devices, storage devices, field-programmable gate arrays (FPGA), and tensor processing units (TPU). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Artificial Intelligence In Oncology Industry?

The artificial intelligence in oncology market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in oncology industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Artificial Intelligence In Oncology Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $2.35 billion
Revenue Forecast In 2034 $7.55 billion
Growth Rate CAGR of 34% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Component: Software Solutions, Hardware, Services
2) By Treatment Type: Chemotherapy, Radiotherapy, Immunotherapy, Other Treatment Types
3) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Cancer Types
4) By Application: Cancer Detection, Drug Discovery, Drug Development, Other Applications
5) By End-Users: Hospitals, Diagnostic Centers, Pharmaceutical Companies, Research Institutes, Other End Users Subsegments: 1) By Software Solutions: Diagnostic Software, Treatment Planning Software, Patient Management Software, Data Analytics Platforms
2) By Hardware: AI-Enabled Imaging Devices, High-Performance Computing Systems, Wearable Health Monitors
3) By Services: Consulting Services, Integration Services, Maintenance And Support Services
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Azra AI, IBM Corporation, Siemens Healthcare GmbH, Intel Corporation, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI Inc., PathAI Inc., Median Technologies SA, Kheiron Medical Technologies Ltd, Hampton Research Inc., Tempus Labs Inc., Paige AI Inc., Prognos Health Inc., Enlitic, Inspirata Inc., Berg LLC, Proscia Inc., Prognos Health Inc., Deep 6 AI Inc., Ibex Medical Analytics, Nanox Imaging Ltd., Zebra Medical Vision, Globavir Biosciences Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Artificial Intelligence In Oncology Market Characteristics

3. Artificial Intelligence In Oncology Market Trends And Strategies

4. Artificial Intelligence In Oncology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence In Oncology Growth Analysis And Strategic Analysis Framework

5.1. Global Artificial Intelligence In Oncology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Artificial Intelligence In Oncology Market Growth Rate Analysis

5.4. Global Artificial Intelligence In Oncology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Artificial Intelligence In Oncology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Artificial Intelligence In Oncology Total Addressable Market (TAM)

6. Artificial Intelligence In Oncology Market Segmentation

6.1. Global Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Software Solutions

Hardware

Services

6.2. Global Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chemotherapy

Radiotherapy

Immunotherapy

Other Treatment Types

6.3. Global Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Breast Cancer

Lung Cancer

Prostate Cancer

Colorectal Cancer

Brain Tumor

Other Cancer Types

6.4. Global Artificial Intelligence In Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cancer Detection

Drug Discovery

Drug Development

Other Applications

6.5. Global Artificial Intelligence In Oncology Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Diagnostic Centers

Pharmaceutical Companies

Research Institutes

Other End Users

6.6. Global Artificial Intelligence In Oncology Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diagnostic Software

Treatment Planning Software

Patient Management Software

Data Analytics Platforms

6.7. Global Artificial Intelligence In Oncology Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

AI-Enabled Imaging Devices

High-Performance Computing Systems

Wearable Health Monitors

6.8. Global Artificial Intelligence In Oncology Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Consulting Services

Integration Services

Maintenance And Support Services

7. Artificial Intelligence In Oncology Market Regional And Country Analysis

7.1. Global Artificial Intelligence In Oncology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Artificial Intelligence In Oncology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence In Oncology Market

8.1. Asia-Pacific Artificial Intelligence In Oncology Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence In Oncology Market

9.1. China Artificial Intelligence In Oncology Market Overview

9.2. China Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence In Oncology Market

10.1. India Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence In Oncology Market

11.1. Japan Artificial Intelligence In Oncology Market Overview

11.2. Japan Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence In Oncology Market

12.1. Australia Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence In Oncology Market

13.1. Indonesia Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence In Oncology Market

14.1. South Korea Artificial Intelligence In Oncology Market Overview

14.2. South Korea Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence In Oncology Market

15.1. Western Europe Artificial Intelligence In Oncology Market Overview

15.2. Western Europe Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence In Oncology Market

16.1. UK Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence In Oncology Market

17.1. Germany Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence In Oncology Market

18.1. France Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence In Oncology Market

19.1. Italy Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence In Oncology Market

20.1. Spain Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence In Oncology Market

21.1. Eastern Europe Artificial Intelligence In Oncology Market Overview

21.2. Eastern Europe Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence In Oncology Market

22.1. Russia Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence In Oncology Market

23.1. North America Artificial Intelligence In Oncology Market Overview

23.2. North America Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence In Oncology Market

24.1. USA Artificial Intelligence In Oncology Market Overview

24.2. USA Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence In Oncology Market

25.1. Canada Artificial Intelligence In Oncology Market Overview

25.2. Canada Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence In Oncology Market

26.1. South America Artificial Intelligence In Oncology Market Overview

26.2. South America Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence In Oncology Market

27.1. Brazil Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence In Oncology Market

28.1. Middle East Artificial Intelligence In Oncology Market Overview

28.2. Middle East Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence In Oncology Market

29.1. Africa Artificial Intelligence In Oncology Market Overview

29.2. Africa Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence In Oncology Market Competitive Landscape And Company Profiles

30.1. Artificial Intelligence In Oncology Market Competitive Landscape

30.2. Artificial Intelligence In Oncology Market Company Profiles

30.2.1. Azra AI Overview, Products and Services, Strategy and Financial Analysis

30.2.2. IBM Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Intel Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.5. GE HealthCare Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence In Oncology Market Other Major And Innovative Companies

31.1. NVIDIA Corporation

31.2. Digital Diagnostics Inc.

31.3. ConcertAI Inc.

31.4. PathAI Inc.

31.5. Median Technologies SA

31.6. Kheiron Medical Technologies Ltd

31.7. Hampton Research Inc.

31.8. Tempus Labs Inc.

31.9. Paige AI Inc.

31.10. Prognos Health Inc.

31.11. Enlitic

31.12. Inspirata Inc.

31.13. Berg LLC

31.14. Proscia Inc.

31.15. Prognos Health Inc.

32. Global Artificial Intelligence In Oncology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence In Oncology Market

34. Recent Developments In The Artificial Intelligence In Oncology Market

35. Artificial Intelligence In Oncology Market High Potential Countries, Segments and Strategies

35.1 Artificial Intelligence In Oncology Market In 2029 - Countries Offering Most New Opportunities

35.2 Artificial Intelligence In Oncology Market In 2029 - Segments Offering Most New Opportunities

35.3 Artificial Intelligence In Oncology Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Artificial Intelligence In Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Artificial Intelligence In Oncology Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Artificial Intelligence In Oncology Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Artificial Intelligence In Oncology Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Artificial Intelligence In Oncology Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Artificial Intelligence In Oncology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Artificial Intelligence In Oncology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Azra AI Financial Performance
  • Table 80: IBM Corporation Financial Performance
  • Table 81: Siemens Healthcare GmbH Financial Performance
  • Table 82: Intel Corporation Financial Performance
  • Table 83: GE HealthCare Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Artificial Intelligence In Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Artificial Intelligence In Oncology Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Artificial Intelligence In Oncology Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Artificial Intelligence In Oncology Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Artificial Intelligence In Oncology Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Artificial Intelligence In Oncology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Artificial Intelligence In Oncology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Artificial Intelligence In Oncology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Artificial Intelligence In Oncology Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Artificial Intelligence In Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Azra AI Financial Performance
  • Figure 80: IBM Corporation Financial Performance
  • Figure 81: Siemens Healthcare GmbH Financial Performance
  • Figure 82: Intel Corporation Financial Performance
  • Figure 83: GE HealthCare Financial Performance

Frequently Asked Questions

Artificial intelligence in oncology refers to applying artificial intelligence (AI) technologies and techniques in cancer diagnosis, treatment, research, and patient care. The goal of AI in oncology is to improve outcomes for cancer patients by leveraging computational methods to identify patterns, predict outcomes, and support evidence-based decision-making across the continuum of cancer care. For further insights on this market, request a sample here

The market major growth driver - AI In Oncology Market Surges As Cancer Incidence Continues To Rise. For further insights on this market, request a sample here

The artificial intelligence in oncology market size has grown exponentially in recent years. It will grow from $1.78 billion in 2024 to $2.35 billion in 2025 at a compound annual growth rate (CAGR) of 31.5%. The growth in the historic period can be attributed to rising cancer incidence, data proliferation in healthcare, clinical trial optimization, demand for personalized medicine, efficiency in radiology and pathology. The artificial intelligence in oncology market size is expected to see exponential growth in the next few years. It will grow to " $7.55 billion in 2029 at a compound annual growth rate (CAGR) of 34.0%. The growth in the forecast period can be attributed to integration with electronic health records (EHR), expanded applications in treatment decision support, patient engagement and education, regulatory support, and standardization. Major trends in the forecast period include integration of natural language processing (NLP) in healthcare, utilization of ai in biomarker discovery, focus on explainable ai for clinical adoption, integration of ai in population health management, collaborations between ai developers and healthcare providers, advancements in predictive analytics. For further insights on this market, request a sample here

The artificial intelligence in oncologymarket covered in this report is segmented –
1) By Component: Software Solutions; Hardware; Services
2) By Treatment Type: Chemotherapy; Radiotherapy; Immunotherapy; Other Treatment Types
3) By Cancer Type: Breast Cancer; Lung Cancer; Prostate Cancer; Colorectal Cancer; Brain Tumor; Other Cancer Types
4) By Application: Cancer Detection; Drug Discovery; Drug Development; Other Applications
5) By End-Users: Hospitals; Diagnostic Centers; Pharmaceutical Companies; Research Institutes; Other End Users Subsegments:
1) By Software Solutions: Diagnostic Software; Treatment Planning Software; Patient Management Software; Data Analytics Platforms
2) By Hardware: AI-Enabled Imaging Devices; High-Performance Computing Systems; Wearable Health Monitors
3) By Services: Consulting Services; Integration Services; Maintenance And Support Services For further insights on this market,
request a sample here

North America was the largest region in the AI in oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the artificial intelligence in oncology market report are Azra AI, IBM Corporation, Siemens Healthcare GmbH, Intel Corporation, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI Inc., PathAI Inc., Median Technologies SA, Kheiron Medical Technologies Ltd., Hampton Research Inc., Tempus Labs Inc., Paige AI Inc., Prognos Health Inc., Enlitic, Inspirata Inc., Berg LLC, Proscia Inc., Prognos Health Inc., Deep 6 AI Inc., Ibex Medical Analytics, Nanox Imaging Ltd., Zebra Medical Vision, Globavir Biosciences Inc.. For further insights on this market, request a sample here.

Major trends in this market include Innovative Cloud-Based Software Revolutionizes AI In Oncology Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top